Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPE for Skin Aging
NCT05457491Phase 1Terminated
- Sponsor
- Mayo Clinic
- Start
- Oct 2021
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in Skin aging, sponsored by Mayo Clinic. Primary endpoints: Change in Redness Area at 6 weeks, Change Brown Spot Area at 6 weeks and 3 more. Started Oct 2021; status: terminated.
02
Conditions
Skin aging
Beyond the preview
Go deeper on NCT05457491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05457491.